Literature DB >> 32360520

Maresin-1 resolution with RORα and LGR6.

Dong-Soon Im1.   

Abstract

Maresin-1, a pro-resolving lipid mediator, is drawing a great deal of attention in receptor pharmacology, largely because two distinct types of receptor molecules have been reported as the targets of maresin-1. One is retinoic acid-related orphan receptor α (RORα) and the other is leucine-rich repeat domain-containing G protein-coupled receptor 6 (LGR6). RORα is a nuclear receptor and LGR6 is a plasma membrane GPCR. Identification of two different molecular targets raises the following question: What are the pro-resolving functions of each receptor in inflammation resolution, host defense, tissue homeostasis, and wound healing? In this article, I review the new targets from the point of view of pharmacology and maresin-1 resolution along with intracellular signaling molecules.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  G protein-coupled receptor; Inflammation; LGR6; Maresin-1; Nuclear receptor; RORα; Resolution

Mesh:

Substances:

Year:  2020        PMID: 32360520     DOI: 10.1016/j.plipres.2020.101034

Source DB:  PubMed          Journal:  Prog Lipid Res        ISSN: 0163-7827            Impact factor:   16.195


  7 in total

1.  Specialized Pro-Resolving Mediators Do Not Inhibit the Synthesis of Inflammatory Mediators Induced by Tumor Necrosis Factor-α in Synovial Fibroblasts.

Authors:  Yuriko Sueda; Ryota Okazaki; Yoshihiro Funaki; Yasuyuki Hasegawa; Hiroki Ishikawa; Yuki Hirayama; Genki Inui; Tomoya Harada; Miki Takata; Masato Morita; Akira Yamasaki
Journal:  Yonago Acta Med       Date:  2022-04-16       Impact factor: 1.371

Review 2.  Molecular Pharmacology of Inflammation Resolution in Atherosclerosis.

Authors:  Stanislav Kotlyarov; Anna Kotlyarova
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

Review 3.  Innate Immunity in Diabetic Wound Healing: Focus on the Mastermind Hidden in Chronic Inflammatory.

Authors:  Kang Geng; Xiumei Ma; Zongzhe Jiang; Wei Huang; Chenlin Gao; Yueli Pu; Lifang Luo; Youhua Xu; Yong Xu
Journal:  Front Pharmacol       Date:  2021-04-21       Impact factor: 5.810

Review 4.  Maresin-1 and Inflammatory Disease.

Authors:  Natsuko Saito-Sasaki; Yu Sawada; Motonobu Nakamura
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

Review 5.  Maresins: The Mainstay in Periodontal Resolution.

Authors:  Hima Bindu Gireddy; Haripriya Rajaram; Rekha R Koduganti; Manasa Ambati; Anilkumar R; Tata Sai Lakshmi Harika
Journal:  Cureus       Date:  2022-01-30

6.  Maresin 1 Alleviates Diabetic Kidney Disease via LGR6-Mediated cAMP-SOD2-ROS Pathway.

Authors:  Xinyue Li; Butuo Xu; Jing Wu; Yueli Pu; Shengrong Wan; Yan Zeng; Mei Wang; Lifang Luo; Fanjie Zhang; Zongzhe Jiang; Yong Xu
Journal:  Oxid Med Cell Longev       Date:  2022-04-19       Impact factor: 7.310

Review 7.  Alzheimer's Disease and Specialized Pro-Resolving Lipid Mediators: Do MaR1, RvD1, and NPD1 Show Promise for Prevention and Treatment?

Authors:  Keishi Miyazawa; Hisanori Fukunaga; Yasuko Tatewaki; Yumi Takano; Shuzo Yamamoto; Tatsushi Mutoh; Yasuyuki Taki
Journal:  Int J Mol Sci       Date:  2020-08-12       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.